Dogwood Therapeutics Inc

DWTX

Company Profile

  • Business description

    Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

  • Contact

    44 Milton Avenue
    AlpharettaGA30009
    USA

    T: +1 866 620-8655

    E: [email protected]

    https://www.virios.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    12

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,743.6030.00-0.34%
CAC 407,691.55134.241.78%
DAX 4024,033.22383.921.62%
Dow JONES (US)43,819.27432.431.00%
FTSE 1008,798.9163.310.72%
HKSE24,284.1541.25-0.17%
NASDAQ20,273.46105.550.52%
Nikkei 22540,150.79566.211.43%
NZX 50 Index12,583.59103.540.83%
S&P 5006,173.0732.050.52%
S&P/ASX 2008,514.2036.60-0.43%
SSE Composite Index3,424.2324.23-0.70%

Market Movers